Cargando…
Efficacy and safety of human umbilical cord-derived mesenchymal stem cells (hUC-MSC PLEB001) for the treatment of grade II–IV steroid-refractory acute graft-versus-host disease: a study protocol for a multicenter, randomized, double-blind, placebo-controlled, phase II trial
BACKGROUND: Systemic corticosteroid therapy failure is quite common in patients with newly diagnosed acute graft-versus-host disease (aGVHD). Growing evidence has suggested that mesenchymal stem cell (MSC) therapy could be a promising treatment option for aGVHD due to its distinctive immunomodulatin...
Autores principales: | Yang, Donglin, Hou, Xiaoqiang, Qian, Kun, Li, Yuhang, Hu, Liangding, Li, Liang, Han, Mingzhe, Yao, Chen, Liu, Daihong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155385/ https://www.ncbi.nlm.nih.gov/pubmed/37138332 http://dx.doi.org/10.1186/s13063-023-07305-0 |
Ejemplares similares
-
Preclinical Evaluation of a Single Intravenous Infusion of hUC-MSC (BX-U001) in Rheumatoid Arthritis
por: Liu, Linan, et al.
Publicado: (2020) -
Peptidome analysis of umbilical cord mesenchymal stem cell (hUC-MSC) conditioned medium from preterm and term infants
por: Wang, Yu, et al.
Publicado: (2020) -
hUC-MSC transplantation therapy effects on lupus-prone MRL/lpr mice at early disease stages
por: Guo, Fengbiao, et al.
Publicado: (2023) -
IV/IT hUC-MSCs Infusion in RRMS and NMO: A 10-Year Follow-Up Study
por: Lu, Zhengjuan, et al.
Publicado: (2020) -
The high level of IL-1β in the serum of ACLF patients induces increased IL-8 expression in hUC-MSCs and reduces the efficacy of hUC-MSCs in liver failure
por: Wang, Yong-Hong, et al.
Publicado: (2023)